Eight in 10 healthcare & pharma clients plan to use consultants more in the next 12 months—a big uptick from last year's report, fuelled by different drivers. This year, buyers are likely to turn to firms not for extra capacity, but for their serious technology expertise. 

In this video briefing, our expert breaks down the market sizing data and survey of 100 healthcare & pharma clients, to highlight the key messages for firms in this dynamic market. 

What's inside? 

• A blueprint of the bright spots: We size the market by region and service line, including the runaway winner of our growth forecasts—cybersecurity consulting. 
• Higher fees, higher expectations: While firms can expect to see price pressure ease, 70% of clients say they want radical solutions from firms. 
• The firms in demand: Find out why over half of healthcare & pharma buyers want to work more with strategy houses—a higher proportion than any other type of firm.  

Why it matters for your firm: 

• Inform strategy with evidence: Use independent data on market confidence, growth, and client demand to guide your strategic direction. 
• Validate investment plans: Ensure resource allocation and initiatives are backed by credible market insight. 
• Accelerate confident decisions: Equip members of your executive team with clear, actionable insight to reach agreement quickly and take decisive action. 

To find out more, access the report or contact us.